Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / Laboratorios Silanes S.A. de C.V.

Clinicaltrial registered28 Oct 2026

Laboratorios Silanes S.A. de C.V.

28 Oct 2026: Trial registered · Study to Evaluate the Efficacy and Safety of Dexketoprofen / Butylscopolamine vs Dexketoprofen in Treatment of Primary Dysmenorrhea. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
28 Oct 2026
Title
Study to Evaluate the Efficacy and Safety of Dexketoprofen / Butylscopolamine vs Dexketoprofen in Treatment of Primary Dysmenorrhea
Conditions
Primary Dysmenorrhea
Phase
Phase 3
Study Type
Interventional
Status
Completed
Countries
Mexico
Country
Mexico
Reference
NCT07901894
Location
Mexico
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Laboratorios Silanes S.A. de C.V.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from Mexico

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.